Replimune Group (NASDAQ:REPL) Price Target Cut to $50.00 by Analysts at HC Wainwright

Replimune Group (NASDAQ:REPL – Free Report) had its price target reduced by HC Wainwright from $51.00 to $50.00 in a report published on Monday, MarketBeat.com reports. They currently have a buy rating on the stock. Separately, Piper Sandler reiterated an overweight rating and issued a $44.00 target price on shares of Replimune Group in a […]

Related Keywords

Colin Love ,Philip Astley Sparke ,Piper Sandler ,Allspring Global Investments Holdings ,Replimune Group Trading Down ,Hedge Funds Weigh In On Replimune Group ,Replimune Group ,Analyst Recommendations For Replimune Group ,Russell Investments Group Ltd ,Replimune Group Inc ,Ameritas Investment Partners Inc ,News Ratings For Replimune Group Daily ,Free Report ,Group Trading Down ,Get Free Report ,Global Investments Holdings ,Investment Partners ,Russell Investments Group ,Replimune Group Daily ,Nasdaq Repl ,Trepl ,Medical ,Lower Price Target ,Hc Wainwright ,